Walsall
Walsall
Walsall, United Kingdom8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo | NonSegmental Vitiligo | Recruiting | Phase 3 | 2026-10-09 | NCT06804811 | |
| WithHolding Enteral Feeds Around Blood Transfusion (International) | Digestive System Diseases, Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, digestive system disorder, enterocolitis, gastroenteritis, intestinal disorder, necrotizing enterocolitis, pregnancy disorder | Recruiting | Not applicable | 2026-09-29 | NCT05213806 | |
| Surveillance of Pancreatic Health After Diabetes Diagnosis | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Nutritional and Metabolic Diseases, Pancreatic cancer, adult, diabetes mellitus, endocrine system disorder, glucose metabolism disease, malignant endocrine neoplasm, metabolic disease, neoplasm, pancreas disorder, pancreatic neoplasm, type 2 diabetes mellitus | Recruiting | Not applicable | 2026-09-28 | NCT06803771 | |
| A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Active, not recruiting | Phase 3 | 2026-08-19 | NCT06832618 | |
| Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2026-07-28 | NCT07067658 | |
| A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2) | NonSegmental Vitiligo | Active, not recruiting | Phase 3 | 2026-03-31 | NCT06113471 | |
| A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, alopecia, alopecia areata, bacterial infectious disease, disorder of pilosebaceous unit, hidradenitis, hidradenitis suppurativa, hypotrichosis, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Not stated | 2026-02-13 | NCT07136467 | |
| Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application | Hernia, Hernia, Abdominal, Hernia, Ventral, Incisional Hernia, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Postoperative Complications | Active, not recruiting | Not stated | 2026-01-21 | NCT05094089 |